Adverum Biotechnologies Inc (ADVM)
8.01
-0.24
(-2.91%)
USD |
NASDAQ |
May 17, 16:00
8.01
0.00 (0.00%)
After-Hours: 20:00
Adverum Biotechnologies Accounts Payable (Quarterly): 1.897M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 1.897M |
December 31, 2023 | 1.921M |
September 30, 2023 | 2.17M |
June 30, 2023 | 1.418M |
March 31, 2023 | 2.863M |
December 31, 2022 | 2.238M |
September 30, 2022 | 0.846M |
June 30, 2022 | 4.698M |
March 31, 2022 | 3.245M |
December 31, 2021 | 1.387M |
September 30, 2021 | 2.517M |
June 30, 2021 | 2.259M |
March 31, 2021 | 2.056M |
December 31, 2020 | 2.81M |
September 30, 2020 | 3.034M |
June 30, 2020 | 10.37M |
March 31, 2020 | 4.663M |
December 31, 2019 | 4.103M |
September 30, 2019 | 3.382M |
June 30, 2019 | 0.74M |
March 31, 2019 | 1.752M |
Date | Value |
---|---|
December 31, 2018 | 1.707M |
September 30, 2018 | 1.736M |
June 30, 2018 | 2.125M |
March 31, 2018 | 0.685M |
December 31, 2017 | 1.731M |
September 30, 2017 | 1.58M |
June 30, 2017 | 1.125M |
March 31, 2017 | 3.383M |
December 31, 2016 | 1.474M |
September 30, 2016 | 3.067M |
June 30, 2016 | 2.419M |
March 31, 2016 | 0.486M |
December 31, 2015 | 0.605M |
September 30, 2015 | 1.141M |
June 30, 2015 | 1.896M |
March 31, 2015 | 2.787M |
December 31, 2014 | 0.951M |
September 30, 2014 | 1.627M |
June 30, 2014 | 1.576M |
March 31, 2014 | 0.946M |
December 31, 2013 | 0.769M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
0.74M
Minimum
Jun 2019
10.37M
Maximum
Jun 2020
2.931M
Average
2.388M
Median
Accounts Payable (Quarterly) Benchmarks
Ligand Pharmaceuticals Inc | 1.893M |
Ardelyx Inc | 17.28M |
Arcus Biosciences Inc | 16.00M |
Arcutis Biotherapeutics Inc | 12.97M |
SeaStar Medical Holding Corp | 4.372M |